Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apellis Pharmaceuticals (APLS) Cash from Operations (2020 - 2025)

Apellis Pharmaceuticals filings provide 6 years of Cash from Operations readings, the most recent being 14176000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations fell 173.22% year-over-year to 14176000.0, compared with a TTM value of 45327000.0 through Dec 2025, up 151.59%, and an annual FY2025 reading of 45327000.0, up 151.59% over the prior year.
  • Cash from Operations hit 14176000.0 in Q4 2025 for Apellis Pharmaceuticals, down from 108468000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 108468000.0 in Q3 2025, with the low at 177620000.0 in Q1 2023.
  • Median Cash from Operations over the past 5 years was 112029500.0 (2021), compared with a mean of 85707250.0.
  • The sharpest move saw Cash from Operations tumbled 179.24% in 2021, then surged 218.13% in 2025.
  • Year by year, Cash from Operations stood at 112499000.0 in 2021, then dropped by 25.11% to 140744000.0 in 2022, then soared by 30.46% to 97875000.0 in 2023, then skyrocketed by 119.78% to 19360000.0 in 2024, then tumbled by 173.22% to 14176000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 14176000.0, 108468000.0, and 4445000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.